Related Experiment Video
Updated: Jan 31, 2026

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
Update on heart failure management and future directions
Hong-Mi Choi1, Myung-Soo Park2, Jong-Chan Youn2
1Division of Cardiology, Hallym University Sacred Heart Hospital, Anyang, Korea.
Insights
Heart failure (HF) management has advanced significantly with new diagnostics and treatments. Ongoing research focuses on improving risk stratification and therapies for better patient outcomes in this growing cardiovascular disease.
Area of Science:
- Cardiology
- Internal Medicine
- Public Health
Background:
- Heart failure (HF) is a major cardiovascular disease with increasing global prevalence, morbidity, mortality, and healthcare costs.
- Korea is experiencing a rise in heart failure cases, mirroring worldwide trends.
- Significant advancements in HF definition, diagnosis, and treatment have occurred over the last 40 years.
Purpose of the Study:
- To review the current state-of-the-art management of heart failure.
- To highlight emerging diagnostic and therapeutic modalities for HF.
- To discuss strategies for improving outcomes in heart failure patients.
Main Methods:
- Literature review of recent advancements in heart failure care.
- Analysis of new diagnostic tools including biomarkers, imaging, and genetic testing.
- Evaluation of novel medications and devices for HF treatment.
Main Results:
- Marked progress in HF definition, diagnostic modalities, and treatment over four decades.
- Adoption of newly developed medications and devices in clinical practice.
- Rapid evolution of definitive treatments for end-stage HF, such as LVAD and transplantation.
Conclusions:
- Continuous efforts are underway to enhance HF risk stratification.
- Emerging therapies and diagnostics show promise for improving HF patient outcomes.
- The review provides insights into current and future directions in heart failure management.
Abstract:
Heart failure (HF) is an important cardiovascular disease because of its increasing prevalence, significant morbidity, high mortality, and rapidly expanding health care cost. The number of HF patients is increasing worldwide, and Korea is no exception. There have been marked advances in definition, diagnostic modalities, and treatment of HF over the past four decades. There is continuing effort to improve risk stratification of HF using biomarkers, imaging and genetic testing. Newly developed medications and devices for HF have been widely adopted in clinical practice. Furthermore, definitive treatment for end-stage heart failure including left ventricular assist device and heart transplantation are rapidly evolving as well. This review summarizes the current state-of-the-art management for HF and the emerging diagnostic and therapeutic modalities to improve the outcome of HF patients.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Diuretics

